Skip to main content
Clinical Trials/NCT03869463
NCT03869463
Terminated
Not Applicable

Testing the Mechanism of Action of Computerized Cognitive Training in Young Adults With Depression: Clinical, Cognitive and Neuroimaging Outcomes

Queens College, The City University of New York1 site in 1 country28 target enrollmentOctober 11, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depressive Symptoms
Sponsor
Queens College, The City University of New York
Enrollment
28
Locations
1
Primary Endpoint
Change in Emotional Go/No Go Task (fMRI)
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The purpose of the study is to examine the benefits and mechanism of action of computerized cognitive training (CCT) on mood, neuropsychological deficits, everyday functioning, and brain activity among young adults with a range of depressive symptoms.

Registry
clinicaltrials.gov
Start Date
October 11, 2019
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Queens College, The City University of New York
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Current diagnosis of MDD/persistent depressive disorder or HDRS greater than or equal to
  • Daily access to smartphone or tablet with internet connection for the study duration.
  • Willing and able to complete MRI, mood, and neuropsychological testing.

Exclusion Criteria

  • Lacks English-speaking ability as determined by self-report and clinical evaluation.
  • Evidence of schizophrenia, schizoaffective disorder, psychosis, bipolar I and II disorder.
  • Active suicidal ideation, intent, or plan, or past attempt within 1 year.
  • Severe depression (HDRS \> 30).
  • Neurological disorder (epilepsy, multiple sclerosis, traumatic brain injury, clinical stroke).
  • Use of medications known to have negative impact on cognition (benzodiazepines and lorazepam equivalents \> 1mg daily, narcotics, anticholinergics).
  • History of alcohol or drug abuse or dependence within past year.
  • Acute, severe, unstable medical illness. For cancer, acutely ill patients (including those with metastases) are excluded, but past history of successfully treated cancer does not result in exclusion.
  • Regular online brain training or regular player of non-fluency verbal games, defined as doing these procedures at a frequency of twice weekly or greater during the year prior to screening.

Outcomes

Primary Outcomes

Change in Emotional Go/No Go Task (fMRI)

Time Frame: Week 0, Week 4 or Week 8 (depending on randomization)

Measure of behavioral inhibition and set shifting. Participants must press a button for pre-specified to go trials and withhold pressing the button for pre-specified no-go trials.

Change in Sheehan Disability Scale

Time Frame: Screen, Week 0, Week 4, Week 8, 3-month follow-up

Self-report questionnaire of everyday functioning. It includes three subscales: work, social life, leisure activities, and home life or family responsibilities. Each subscale is rated on a 10-point scale for a minimum total score of 0 and a maximum total summed score of 30 across the three subscales. High scores are associated with more impairment.

Change in Hamilton Depression Rating Scale

Time Frame: Screen, Week 0, Week 4, Week 8, 3-month follow-up

Clinician-rated measure of depression composed of 21 questions. The first 17 items are scored: eight items have a 5-point scale, nine items have a 3-point scale. Total score range is 0-52. Higher scores indicate more severe symptoms.

Change in DKEFS Trail Making Test - Condition 4

Time Frame: Weeks 0, 4, 8, 3-month follow- up

Measure of executive function. It is a switching task that requires the subject to connect numbers and letters in an alternating pattern (1-A-2-B, etc.) as quickly as possible.

Secondary Outcomes

  • Change in Beck Depression Inventory-II(Screen, weekly for weeks 0-8, 3-month follow-up)
  • Change in WAIS-IV Coding(Weeks 0, 4, 8, 3-month follow- up)
  • Change in Connectivity Index (resting state fMRI)(Week 0, Week 4 or Week 8 (depending on randomization))

Study Sites (1)

Loading locations...

Similar Trials